US Stock MarketDetailed Quotes

ADILW Adial Pharmaceuticals Inc C/ Wts 31/07/2023 (To Pur Com)

Watchlist
  • 0.0009
  • 0.00000.00%
Close Jul 28 09:30 ET
0Market Cap0.00P/E (TTM)

Adial Pharmaceuticals Inc C/ Wts 31/07/2023 (To Pur Com) Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
(FY)Dec 31, 2021
(Q4)Dec 31, 2021
(Q3)Sep 30, 2021
(Q2)Jun 30, 2021
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-4.52%2.92M
-24.93%13.32M
-26.91%3.24M
-21.55%3.19M
-13.02%3.83M
-36.80%3.06M
62.34%17.74M
27.72%4.43M
21.72%4.06M
142.12%4.4M
Selling and administrative expenses
-8.87%2.24M
-2.19%9.14M
0.17%2.1M
-18.03%1.94M
26.17%2.63M
-11.69%2.46M
84.14%9.34M
49.20%2.1M
59.06%2.37M
123.97%2.08M
-General and administrative expense
-8.87%2.24M
-2.19%9.14M
0.17%2.1M
-18.03%1.94M
26.17%2.63M
-11.69%2.46M
84.14%9.34M
49.20%2.1M
59.06%2.37M
123.97%2.08M
Research and development costs
13.43%676.44K
-50.25%4.18M
-51.27%1.14M
-26.49%1.24M
-48.25%1.2M
-70.93%596.34K
43.43%8.4M
13.07%2.33M
-8.42%1.69M
161.15%2.32M
Operating profit
4.52%-2.92M
24.93%-13.32M
26.91%-3.24M
21.55%-3.19M
13.02%-3.83M
36.80%-3.06M
-62.34%-17.74M
-27.72%-4.43M
-21.72%-4.06M
-142.12%-4.4M
Net non-operating interest income expense
464.85%28.89K
866.65%63.21K
2,072.69%47.82K
16.81%3.34K
486.79%6.93K
1,633.90%5.12K
-79.88%6.54K
63.16%2.2K
13.03%2.86K
-77.21%1.18K
Non-operating interest income
464.85%28.89K
866.65%63.21K
2,072.69%47.82K
16.81%3.34K
486.79%6.93K
1,633.90%5.12K
-79.88%6.54K
63.16%2.2K
13.03%2.86K
-77.21%1.18K
Other net income (expense)
-109.59%-14K
129.27%522K
121.75%325K
129.17%75K
37.48%-24K
2,226.69%146K
-71,444.64%-1.78M
-1.49M
-257.12K
-1,635.60%-38.39K
Special income (charges)
-109.59%-14K
128.52%522K
121.75%325K
127.32%75K
64.43%-24K
2,226.69%146K
---1.83M
---1.49M
---274.52K
---67.48K
-Less:Restructuring and merger&acquisition
109.59%14K
-285.29%-522K
-501.70%-325K
-127.32%-75K
-64.43%24K
-2,226.69%-146K
--281.71K
---54.01K
--274.52K
--67.48K
-Write off
----
--0
----
----
----
----
--1.55M
----
----
----
Other non- operating income (expenses)
----
----
----
----
----
----
1,759.76%46.49K
--0
--17.41K
1,063.52%29.09K
Income before tax
0.07%-2.91M
34.77%-12.73M
51.61%-2.87M
27.99%-3.11M
13.36%-3.85M
39.84%-2.91M
-79.17%-19.52M
-70.78%-5.92M
-29.44%-4.32M
-145.21%-4.44M
Income tax
0
99.47%-502
99.47%-502
0
0
0
-94.08K
-94.08K
0
0
Net income
0.07%-2.91M
34.45%-12.73M
50.84%-2.87M
27.99%-3.11M
13.36%-3.85M
39.84%-2.91M
-78.31%-19.42M
-68.07%-5.83M
-29.44%-4.32M
-145.21%-4.44M
Net income continuous Operations
0.07%-2.91M
34.45%-12.73M
50.84%-2.87M
27.99%-3.11M
13.36%-3.85M
39.84%-2.91M
-78.31%-19.42M
-68.07%-5.83M
-29.44%-4.32M
-145.21%-4.44M
Minority interest income
Net income attributable to the parent company
0.07%-2.91M
34.45%-12.73M
50.84%-2.87M
27.99%-3.11M
13.36%-3.85M
39.84%-2.91M
-78.31%-19.42M
-68.07%-5.83M
-29.44%-4.32M
-145.21%-4.44M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
0.07%-2.91M
34.45%-12.73M
50.84%-2.87M
27.99%-3.11M
13.36%-3.85M
39.84%-2.91M
-78.31%-19.42M
-68.07%-5.83M
-29.44%-4.32M
-145.21%-4.44M
Basic earnings per share
Diluted earnings per share
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022(FY)Dec 31, 2021(Q4)Dec 31, 2021(Q3)Sep 30, 2021(Q2)Jun 30, 2021
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -4.52%2.92M-24.93%13.32M-26.91%3.24M-21.55%3.19M-13.02%3.83M-36.80%3.06M62.34%17.74M27.72%4.43M21.72%4.06M142.12%4.4M
Selling and administrative expenses -8.87%2.24M-2.19%9.14M0.17%2.1M-18.03%1.94M26.17%2.63M-11.69%2.46M84.14%9.34M49.20%2.1M59.06%2.37M123.97%2.08M
-General and administrative expense -8.87%2.24M-2.19%9.14M0.17%2.1M-18.03%1.94M26.17%2.63M-11.69%2.46M84.14%9.34M49.20%2.1M59.06%2.37M123.97%2.08M
Research and development costs 13.43%676.44K-50.25%4.18M-51.27%1.14M-26.49%1.24M-48.25%1.2M-70.93%596.34K43.43%8.4M13.07%2.33M-8.42%1.69M161.15%2.32M
Operating profit 4.52%-2.92M24.93%-13.32M26.91%-3.24M21.55%-3.19M13.02%-3.83M36.80%-3.06M-62.34%-17.74M-27.72%-4.43M-21.72%-4.06M-142.12%-4.4M
Net non-operating interest income expense 464.85%28.89K866.65%63.21K2,072.69%47.82K16.81%3.34K486.79%6.93K1,633.90%5.12K-79.88%6.54K63.16%2.2K13.03%2.86K-77.21%1.18K
Non-operating interest income 464.85%28.89K866.65%63.21K2,072.69%47.82K16.81%3.34K486.79%6.93K1,633.90%5.12K-79.88%6.54K63.16%2.2K13.03%2.86K-77.21%1.18K
Other net income (expense) -109.59%-14K129.27%522K121.75%325K129.17%75K37.48%-24K2,226.69%146K-71,444.64%-1.78M-1.49M-257.12K-1,635.60%-38.39K
Special income (charges) -109.59%-14K128.52%522K121.75%325K127.32%75K64.43%-24K2,226.69%146K---1.83M---1.49M---274.52K---67.48K
-Less:Restructuring and merger&acquisition 109.59%14K-285.29%-522K-501.70%-325K-127.32%-75K-64.43%24K-2,226.69%-146K--281.71K---54.01K--274.52K--67.48K
-Write off ------0------------------1.55M------------
Other non- operating income (expenses) ------------------------1,759.76%46.49K--0--17.41K1,063.52%29.09K
Income before tax 0.07%-2.91M34.77%-12.73M51.61%-2.87M27.99%-3.11M13.36%-3.85M39.84%-2.91M-79.17%-19.52M-70.78%-5.92M-29.44%-4.32M-145.21%-4.44M
Income tax 099.47%-50299.47%-502000-94.08K-94.08K00
Net income 0.07%-2.91M34.45%-12.73M50.84%-2.87M27.99%-3.11M13.36%-3.85M39.84%-2.91M-78.31%-19.42M-68.07%-5.83M-29.44%-4.32M-145.21%-4.44M
Net income continuous Operations 0.07%-2.91M34.45%-12.73M50.84%-2.87M27.99%-3.11M13.36%-3.85M39.84%-2.91M-78.31%-19.42M-68.07%-5.83M-29.44%-4.32M-145.21%-4.44M
Minority interest income
Net income attributable to the parent company 0.07%-2.91M34.45%-12.73M50.84%-2.87M27.99%-3.11M13.36%-3.85M39.84%-2.91M-78.31%-19.42M-68.07%-5.83M-29.44%-4.32M-145.21%-4.44M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 0.07%-2.91M34.45%-12.73M50.84%-2.87M27.99%-3.11M13.36%-3.85M39.84%-2.91M-78.31%-19.42M-68.07%-5.83M-29.44%-4.32M-145.21%-4.44M
Basic earnings per share
Diluted earnings per share
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg